269 results
Page 4 of 14
8-K
EX-99.1
m1siu2pe6y6u
13 Nov 20
Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Treatment of Postoperative Pain
8:40am
8-K
EX-99.1
15nljzxxz dmjofaj3
5 Nov 20
Results of Operations and Financial Condition
8:40am
8-K
EX-99.1
1ha8an1d
28 Sep 20
Heron Therapeutics Receives European Commission Authorization for ZYNRELEFTM (HTX-011) for the Treatment of Postoperative Pain
8:41am
8-K
EX-99.1
wnf1ij2w255w0dr8z5
16 Sep 20
Regulation FD Disclosure
8:40am
8-K
EX-99.1
qlfhtj
8 Sep 20
Heron Therapeutics Announces Successful Outcome of FDA Type A Meeting to Discuss HTX-011 for the Management of Postoperative Pain
8:41am
8-K
EX-99.1
3qz xqttf2g
5 Aug 20
Results of Operations and Financial Condition
4:10pm
8-K
EX-99.1
gk1s02l 95u08
24 Jul 20
Heron Therapeutics Receives Positive CHMP Opinion for ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain
8:40am
8-K
EX-99.1
aspmzrzu
16 Jul 20
Heron Therapeutics Announces Initiation of
8:40am
8-K
EX-99.1
cutk wx5jqb0
29 Jun 20
Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain
4:06pm
8-K
EX-99.1
2uwxm3ej
4 Jun 20
Regulation FD Disclosure
9:14am
8-K
EX-99.1
ip2yu9q4iawv r5
18 May 20
Heron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative Pain
9:11am
8-K
EX-99.1
w1unukodh
6 May 20
Results of Operations and Financial Condition
9:10am
8-K
EX-99.1
6wj03
2 Mar 20
Results of Operations and Financial Condition
7:44am
8-K
EX-99.1
lvw330o j8ewm84
19 Feb 20
Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for the Management of Postoperative Pain
4:37pm
8-K
EX-99.2
u5fnrb464 1psf8nj1
13 Jan 20
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
8:41am
8-K
EX-99.1
dy56j1gyf 59
13 Jan 20
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
8:41am